Loading clinical trials...
Loading clinical trials...
To evaluate the ability of \[68Ga\]N188 to detect nectin-4 overexpression in patients with lung lesions.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Peking University Cancer Hospital & Institute
NCT07219251 · Lung Cancer (NSCLC), Lung Adenocarcinoma, and more
NCT06405230 · Lung Cancer, Non-Small Cell
NCT04940936 · Decision Making, Shared, Stereotactic Body Radiation Therapy, and more
NCT05620329 · Lung Cancer, Lung Infection, and more
NCT06659042 · Lung Cancer, Non-Small Cell
Peking University Cancer Hospital & Institute
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions